Ireland· IE-PA-PA0822/124/001
Depo-Provera 150 mg/ml Suspension for Injection
A medroxyprogesterone product containing medroxyprogesterone acetate, registered in Ireland by Pfizer Healthcare Ireland Unlimited Company. The same ATC class is registered in 11 of our 19 countries.
Checked against HPRA (Ireland) on
Informational only — not a medical device.
Where it is registered
Medroxyprogesterone is registered in 11 of 19 countries.
Countries holding a registration under ATC G03AC06 (medroxyprogesterone), each read from that country’s own register.
- This record: Ireland, from HPRA (Ireland)
- 7 of them publish a price we can compare per daily dose
Medroxyprogesterone · ATC G03AC06
11 / 19 countries
- Belgiumprice
- Canada
- Czechiaprice
- Denmark
- Finlandprice
- Icelandprice
- Ireland
- Netherlands
- Norwayprice
- Polandprice
- Switzerlandprice
The record
At a glance
HPRA (Ireland)- Active substance
- Medroxyprogesterone acetate
- Manufacturer
- Pfizer Healthcare Ireland Unlimited Company
- Country
- Ireland (IE)
- ATC code
- G03AC06
- ATC class
- Medroxyprogesterone
- Defined daily dose
- 1.67 mg, P
- Reimbursed
- Not published by this register
- Source register
- HPRA (Ireland)
- Last checked
- September 28, 2026
Packs & prices · 1
- ie_pa_numberPA0822/124/001
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Interactions
245 interactions on record for medroxyprogesterone.
Graded by severity as the source publishes them — 21 severe. Severity grades are free for everyone; mechanism and management come with Growth.
- Severity for every pair — free, no plan needed
- The source, licence and sync date on every record
- Mechanism and what to do for each pair — Growth plan
Medroxyprogesterone · interactions on record
245 records
- 21 severe
- 213 moderate
- 7 minor
Most severe, free to view
- Tranexamic acidB02AA02severe
- BosentanC02KX01severe
- GriseofulvinD01AA08severe
- GriseofulvinD01BA01severe
4 more interactions with mechanism and management, from a commercially licensed source.
Sign in to check- Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Same medicine, other countries
Medroxyprogesterone in 17 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- United StatesDepo-ProveraPharmacia & Upjohn Company LLC
- NetherlandsDepo-Provera 150, suspensie voor injectie 150 mg/mlPfizer B.V.
- United KingdomAdgyn Medro 5mg tabletsKyowa Kirin Ltd
- FinlandCykrinaWyeth Medica Ireland
- BelgiumDepo-Provera 1000, 1000 mgPfizer
- CzechiaDEPO-PROVERAPfizer, spol. s r.o., Praha
- CanadaAA-MEDROXYAA PHARMA INC
- Japanメドロキシプロゲステロン酢酸エステルファイザー
Authorised across Europe · EMA
The same active substance is authorised in 22 EEA countries. Names it is sold under:
- Austria · Depocon, Farlutal
- Belgium · Depo-Provera, Provera
- Bulgaria · Фарлутал
- Czechia · Depo-Provera, Provera
- Germany · Depo-Clinovir, Mpa
- Denmark · Depo-Provera, Provera
- Estonia · Farlutal
- Spain · Depo-Progevera, Progevera
- Finland · Farlutal, Provera
- France · Depo Prodasone, Depo Provera
- United Kingdom (Northern Ireland) · Depo-Provera, Medroxyprogesterone Acetate Pfizer
- Croatia · Provera
- Hungary · Depo-Provera, Provera
- Iceland · Depo-Provera
- Italy · Depo-Provera, Farlutal
- Luxembourg · Depo-Provera, Provera
- Latvia · Depo-Provera
- Netherlands · Depo-Provera, Provera
- Norway · Depo-Provera, Provera
- Poland · Depo-Provera, Provera
- Portugal · Depo-Provera 150
- Sweden · Depo-Provera, Provera
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of HPRA (Ireland). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/94c0212d-2c16-410d-ac4b-ee319252687d GET /v1/drugs/94c0212d-2c16-410d-ac4b-ee319252687d?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"form": "Suspension for injection",
"routes": [
"Intramuscular use"
],
"source": "hpra",
"atc_all": [
"G03AC",
"G03AC06"
],
"strength": null,
"pa_number": "PA0822/124/001",
"substances": [
"Medroxyprogesterone acetate"
],
"legal_basis": "Full application (Article 8(3) of Directive No 2001/83/EC)",
"market_info": "Marketed",
"authorised_at": "19/01/1996",
"dispensing_status": "Product subject to prescription which may not be renewed (A)",
"registration_status": "AU",
"supply_legal_status": "Supply through pharmacies only",
"interchangeable_code": null
}See everything about medroxyprogesterone.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.